| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |